Save £40: Complete Wegovy vs Mounjaro Price Breakdown
Wegovy Comparison Guide: Understanding Your Discount Options
When conducting a wegovy comparison with Mounjaro, the discount structure becomes a crucial factor in your decision-making process. EverydayMeds offers transparent pricing for both treatments, with new customers accessing code FIRST40 and returning customers using DOSE25 at checkout. These codes are automatically applied to reach our competitive prices, ensuring you receive the best value regardless of which treatment your prescriber recommends. The wegovy comparison reveals that while both are prescription-only medicines, their pricing structures differ significantly due to different dosing approaches and manufacturer pricing strategies.
Our wegovy comparison pricing reflects the complete treatment journey, from starter doses through maintenance therapy. Wegovy follows a structured 20-week dose escalation schedule, beginning at 0.25mg for £79.99 and progressing to the maintenance dose of 2.4mg at £209.99. This transparent pricing structure allows you to budget effectively for your weight management journey. Meanwhile, Mounjaro starts at a higher price point of £149.99 but follows a different escalation pattern, making direct wegovy comparison essential for understanding long-term costs.
Comprehensive Wegovy Comparison Pricing Structure
The wegovy comparison pricing at EverydayMeds demonstrates our commitment to accessible weight management solutions. Single pen prices start with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and reaching the maintenance 2.4mg dose at £209.99. Our bundle options provide convenience for treatment continuity, with the Intro Duo (0.25mg & 0.5mg) available for £169.99 and the Progress Duo (0.5mg & 1mg) at £189.99. These prices already reflect the discount codes applied at checkout, ensuring transparency without hidden calculations.
For patients requiring extended treatment periods, our wegovy comparison includes three-pen bundles designed for treatment stability. The Intro Trio covering your first three dose increases costs £299.99, while the Ultimate Stability Trio providing three months of 2.4mg maintenance therapy is available for £649.99. When comparing these options in your wegovy comparison analysis, remember that bundles offer convenience benefits including Reliable Supply continuity and reduced ordering frequency. All prices shown represent the final cost after discount codes FIRST40 or DOSE25 are applied during checkout.
Clinical Evidence in Wegovy Comparison Context
The wegovy comparison clinical evidence demonstrates distinct efficacy profiles for each treatment option. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight management of approximately 15.2% at two years, indicating long-term effectiveness when used as part of a comprehensive weight management programme.
When conducting a wegovy comparison with Mounjaro's clinical data, it's important to note that direct comparisons aren't appropriate due to different trial designs and patient populations. Both treatments have demonstrated significant efficacy in their respective clinical programmes, and both are available through EverydayMeds with the same rigorous prescriber review process. Your prescriber can help determine which treatment aligns better with your individual health profile and weight management goals based on the complete clinical picture rather than trial statistics alone.
Wegovy Comparison: Mechanism of Action Differences
Understanding the mechanistic differences forms a crucial part of any wegovy comparison analysis. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which is released by the intestines after eating. This mechanism reduces appetite by acting on brain appetite centres, promotes feelings of fullness after smaller meals, and may help reduce food cravings throughout the day. The once-weekly injection delivers consistent medication levels, supporting appetite regulation between doses. In contrast, Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, targeting two incretin pathways simultaneously, which represents a different pharmacological approach to weight management.
Streamlined Ordering Process for Wegovy Comparison Choices
EverydayMeds simplifies the wegovy comparison decision-making process through our comprehensive online service. The journey begins with a 3-minute clinical assessment covering your medical history, current medications, and weight management goals, allowing our prescribers to evaluate both Wegovy and Mounjaro suitability. Following assessment submission, our qualified prescribers review your case within 3 working days (or 24 hours with express service), providing personalised treatment recommendations based on your individual circumstances. Once approved, your chosen treatment ships via next-day delivery using temperature-controlled, cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet UK regulatory standards, while discount codes FIRST40 or DOSE25 are applied automatically at checkout. This streamlined process eliminates the complexity often associated with wegovy comparison shopping, providing clear guidance from clinical assessment through to doorstep delivery.
Storage and Practical Considerations in Wegovy Comparison
Storage requirements present an important practical factor in your wegovy comparison evaluation. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer superior travel convenience with up to 6 weeks of room temperature storage below 30°C once removed from refrigeration. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy more suitable for frequent travelers or those with variable schedules. The wegovy comparison also reveals that both treatments use pre-filled injection pens - Wegovy utilises Novo Nordisk's FlexTouch pen technology, while Mounjaro uses Eli Lilly's KwikPen system. Both pens are designed for once-weekly administration and include dose escalation schedules that must be followed precisely, though Wegovy's 20-week escalation differs from Mounjaro's 12-week schedule, affecting both cost timing and treatment progression planning.
Wegovy Comparison Discount Strategy: Maximising Value
Smart wegovy comparison shopping extends beyond initial pen prices to encompass the complete treatment value proposition. Our discount codes FIRST40 and DOSE25 apply to all treatment options, whether you choose Wegovy or Mounjaro following prescriber consultation. The wegovy comparison value calculation should include the longer room temperature storage capability, potentially reducing waste from temperature excursions during travel or power outages. Additionally, Wegovy's established clinical track record and longer market presence may provide confidence for some patients, while others may prefer Mounjaro's dual-mechanism approach.
When finalising your wegovy comparison decision, consider that EverydayMeds provides identical service standards for both treatments - the same clinical assessment process, prescriber review timeframes, cold-chain delivery, and customer support access. This consistency means your wegovy comparison can focus purely on clinical suitability and cost considerations rather than service quality differences. Both treatments require identical commitment to reduced-calorie diet and increased physical activity for optimal results, making the comparison primarily about mechanism preference and individual response patterns rather than lifestyle compatibility differences.
Complete Your Wegovy Comparison Today
Your wegovy comparison journey concludes with actionable next steps through EverydayMeds' comprehensive service. Both Wegovy and Mounjaro remain available through our platform, with new customers using discount code FIRST40 and returning customers applying DOSE25 at checkout to access our competitive pricing. Our qualified prescribers provide personalised recommendations based on your individual clinical assessment, removing the guesswork from your wegovy comparison decision. The 3-minute online assessment captures the necessary information for expert treatment selection, whether you ultimately choose Wegovy's proven GLP-1 approach or Mounjaro's innovative dual-pathway mechanism. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and access either treatment option with complete confidence in our GPhC-registered service standards. Remember that both treatments represent prescription-only medicines requiring ongoing commitment to lifestyle modifications for optimal weight management results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
